COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20130812014333N164


Column Value
Trial registration number IRCT20130812014333N164
Full text link
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dr. Farid Najafi

Contact
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

fnajafi@kums.ac.ir

Registration date
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-04-01

Recruitment status
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Infected patients with Corona virus based on CRISPR test (PCR) Diagnosis of acute respiratory syndrome according to Berlin criteria Requires oxygenation or confirmed pneumonia by radiologically or CT Oxygen uptake concentration Progression of of pulmonary edema more than 50% within 24-48 hours Mild to moderate pneumonia caused by a new coronavirus

Exclusion criteria
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Serious underlying illness or psychosis Co-infection with HIV, tuberculosis, influenza virus, adenovirus and other viral respiratory infections Liver or kidney SOFA score more than 3

Number of arms
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Kermanshah University of Medical Sciences

Inclusion age min
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

0

Inclusion age max
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

8

primary outcome
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Oxygen saturation Neutrophil to lymphocyte ratio Ferritin

Notes
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2/Phase 3

Arms
Last imported at : April 2, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 788, "treatment_name": "Mesenchymal stem cells exosomes", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]